Activation of extracellular signal-regulated kinases (ERK) during reperfusion of ischemic spinal cord

Molecular Brain Research

Volumn 115, Issue 2, 2003, Pages 173-186

  Shackelford, Deborah A ^a   Yeh, Richard Y ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

ERK; Ischemia; JNK SAPK; MAP kinase; Reperfusion; Spinal cord

Indexed keywords

MITOGEN ACTIVATED PROTEIN KINASE 1; STRESS ACTIVATED PROTEIN KINASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; ENZYME ACTIVITY; ENZYME INDUCTION; ENZYME LOCALIZATION; ENZYME PHOSPHORYLATION; GLIA CELL; IMMUNOHISTOCHEMISTRY; MOTONEURON; MOTOR PERFORMANCE; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; RABBIT; REPERFUSION INJURY; SPINAL CORD ISCHEMIA; TISSUE DISTRIBUTION;

ANIMALIA; ORYCTOLAGUS CUNICULUS;

EID: 0037769890     PISSN: 0169328X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0169-328X(03)00206-7     Document Type: Article

References (59)

1. Alessandrini A., Namura S., Moskowitz M.A., Bonventre J.V. MEK1 protein kinase inhibition protects against damage resulting from focal cerebral ischemia. Proc. Natl. Acad. Sci. USA. 96:1999;12866-12869.
2. Bading H., Greenberg M.E. Stimulation of protein tyrosine phosphorylation by NMDA receptor activation. Science. 253:1991;912-914.
3. Bhat N.R., Zhang P. Hydrogen peroxide activation of multiple mitogen-activated protein kinases in an oligodendrocyte cell line: roll of extracellular signal-regulated kinase in hydrogen peroxide-induced cell death. J. Neurochem. 72:1999;112-119.
4. Boulton T.G., Cobb M.H. Identification of multiple extracellular signal-regulated kinases (ERKs) with antipeptide antibodies. Cell Regulation. 2:1991;357-371.
5. Bueno O.F., De Windt L.J., Tymitz K.M., Witt S.A., Kimball T.R., Klevitsky R., E Hewett T., Jones S.P., Lefer D.J., Peng C.-F., Kitsis R.N., Molkentin J.D. The MEK1-ERK1/2 signaling pathway promotes compensated cardiac hypertrophy in transgenic mice. EMBO J. 19:2000;6341-6350.
6. Bush T.G., Puvanachandra N., Horner C.H., Polito A., Ostenfeld T., Svendsen C.N., Mucke L., Johnson M.H., Sofroniew M.V. Leukocyte infiltration, neuronal degeneration, and neurite outgrowth after ablation of scar-forming, reactive astrocytes in adult transgenic mice. Neuron. 23:1999;297-308.
7. Campos-Gonzalez R., Kindy M.S. Tyrosine phosphorylation of microtubule-associated protein kinase after transient ischemia in the gerbil brain. J. Neurochem. 59:1992;1955-1958.
8. Chang L., Karin M. Mammalian MAP kinase signalling cascades. Nature. 410:2001;37-40.
9. Creedon D.J., Johnson E.M. Jr., Lawrence J.C. Jr. Mitogen-activated protein kinase-independent pathways mediate the effects of nerve growth factor and cAMP on neuronal survival. J. Biol. Chem. 271:1996;20713-20718.
10. Fiore R.S., Bayer V.E., Pelech S.L., Posada J., Cooper J.A., Barban J.M. p42 mitogen-activated protein kinase in brain: prominent localization in neuronal cell bodies and dendrites. Neuroscience. 55:1993;463-472.
11. Fiore R.S., Murphy T.H., Sanghera J.S., Pelech S.L., Baraban J.M. Activation of p42 mitogen-activated protein kinase by glutamate receptor stimulation in rat primary cortical cultures. J. Neurochem. 61:1993;1626-1633.
12. MAPK and JNK1, and their regulatory kinases MEK1 and MEK4, in adult rat central nervous system. J. Comp. Neurol. 398:1998;373-392.
13. Garrington T.P., Johnson G.L. Organization and regulation of mitogen-activated protein kinase signaling pathways. Curr. Opin. Cell Biol. 11:1999;211-218.
14. Gonzalez-Zulueta M., Feldman A.B., Klesse L.J., Klab R.G., Dillman J.F., Parada L.F., Dawson T.M., Dawson V.L. Requirement for nitric oxide activation of p21 ras/extracellular regulated kinase in neuronal ischemic preconditioning. Proc. Natl. Acad. Sci. USA. 97:2000;436-441.
15. Gu Z., Jiang Q., Zhang G. Extracellular signal-regulated kinase 1/2 activation in hippocampus after cerebral ischemia may not interfere with postischemic cell death. Brain Res. 901:2001;79-84.
16. Gu Z., Jiang Q., Zhang G., Cui Z., Zhu Z. Diphosphorylation of extracellular signal-regulated kinases and c-Jun N-terminal protein kinases in brain ischemic tolerance in rat. Brain Res. 860:2000;157-160.
17. 2/role in cell survival following oxidant injury. J. Biol. Chem. 271:1996;4138-4142.
18. Hibi M., Lin A., Smeal T., Minden A., Karin M. Identification of an oncoprotein- and UV-responsive protein kinase that binds and potentiates the c-Jun activation domain. Genes Dev. 7:1993;2135-2148.
19. Hodges C., Liao J., Stofega M., Guan K., Carter-Su C., Schwartz J. Growth hormone stimulates phosphorylation and activation of Elk-1 and expression of c-fos, egr-1, and junB through activation extracellular signal-regulated kinases 1 and 2. J. Biol. Chem. 273:1998;31327-31336.
20. Hu B.-R., Liu C., Park D. Alteration of MAP kinase pathways after transient forebrain ischemia. J. Cereb. Blood Flow Metab. 20:2000;1089-1095.
21. Hu B.-R., Wieloch T. Tyrosine phosphorylation and activation of mitogen-activated protein kinase in the rat brain following transient cerebral ischemia. J. Neurochem. 62:1994;1357-1367.
22. Ip Y.T., Davis R.J. Signal transduction by the c-Jun N-terminal kinase (JNK)-from inflammation to development. Curr. Opin. Cell Biol. 10:1998;205-219.
23. Irving E.A., Bamford M. Role of mitogen-and stress-activated kinases in ischemic injury. J. Cereb. Blood Flow Metab. 22:2002;631-647.
24. Irving E.A., Barone F.C., Reith A.D., Hadingham S.J., Parsons A.A. Differential activation of MAPK/ERK and p38/SAPK in neurones and glia following focal cerebral ischaemia in the rat. Mol. Brain Res. 77:2002;65-75.
25. Kanterewicz B., T Knapp L., Klann E. Stimulation of p42 and p44 mitogen-activated protein kinase by reactive oxygen species and nitric oxide in hippocampus. J. Neurochem. 70:1998;1009-1016.
26. Kummer J.L., Rao P.K., Heidenreich K.A. Apoptosis induced by withdrawal of trophic factors is mediated by p38 mitogen-activated protein kinase. J. Biol. Chem. 272:1997;20490-20494.
27. Lowry O.H., Rosebrough N.J., Farr A.L., Randall R.J. Protein measurement with Folin phenol reagent. J. Biol. Chem. 193:1951;265-272.
28. Mandell J.W., Gocan N.C., VandenBerg S.R. Mechanical trauma induces rapid astroglial activation of ERK/MAP kinase: evidence for a paracrine signal. Glia. 34:2001;283-295.
29. Mandell J.W., VandenBerg S.R. ERK/MAP kinase is chronically activated in human reactive astrocytes. NeuroReport. 10:1999;3567-3572.
30. Marshall C.J. Specificity of receptor tyrosine kinase signaling: transient versus sustained extracellular signal-regulated kinase activation. Cell. 80:1995;179-185.
31. Mielke K., Herdegen T. JNK and p38 stress kinases - degenerative effectors of signal-transduction-cascades in the nervous system. Prog. Neurobiol. 61:2000;45-60.
32. Mori T., Wang X., Aoki T., Lo E.H. Downregulation of matrix metalloproteinase-9 and attenuation of edema via inhibition of ERK mitogen activated protein kinase in traumatic brain injury. J. Neurotrauma. 19:2002;1411-1419.
33. Mori T., Wang X., Jung J.-C., Sumii T., Singhal A.B., Fini M.E., Dixon C.E., Alessandrini A., Lo E.H. Mitogen-activated protein kinase inhibition in traumatic brain injury: in vitro and in vitro effects. J. Cereb. Blood Flow Metab. 22:2002;444-452.
34. Murray B., Alessandrini A., Cole A.J., Yee A.G., Furshpan E.J. Inhibition of the p44/42 MAP kinase pathway protects hippocampal neurons in a cell-culture model of seizure activity. Proc. Natl. Acad. Sci. USA. 95:1998;11975-11980.
35. Namura S., Iihara K., Takami S., Nagata I., Kikuchi H., Matsushita K., Moskowitz M.A., Bonventre J.V., Alessandrini A. Intravenous administration of MEK inhibitor U0126 affords brain protection against forebrain ischemia and focal cerebral ischemia. Proc. Natl. Acad. Sci. USA. 98:2001;11569-11574.
36. Noshita N., Sugawara T., Hayashi T., Lewen A., Omar G., Chan P.H. Copper/zinc superoxide dismutase attenuates neuronal cell death by preventing extracellular signal-regulated kinase activation after transient focal cerebral ischemia in mice. J. Neurosci. 22:2002;7923-7930.
37. Nozaki K., Nishimura M., Hashimoto N. Mitogen-activated protein kinases and cerebral ischemia. Mol. Neurobiol. 23:2001;1-19.
38. Park J.A., Koh J.-Y. Induction of an immediate early gene egr-1 by zinc through extracellular signal-regulated kinase activation in cortical culture: its role in zinc-induced neuronal death. J. Neurochem. 73:1999;450-456.
39. Rosen L.B., Ginty D.D., Weber M.J., Greenberg M.E. Membrane depolarization and calcium influx stimulate MEK and MAP kinase via activation of ras. Neuron. 12:1994;1207-1221.
40. Roy M., Sapolsky R.M. Neuronal apoptosis in acute necrotic insults: why is this subject a mess? Trend. Neurosci. 22:1999;419-422.
41. Runden E., Seglen P.O., Haug F.-M., Ottersen O.P., Wieloch T., Shamloo M., Laake J.H. Regional selective neuronal degeneration after protein phosphatase inhibition in hippocampal slice cultures: evidence for a MAP kinase-dependent mechanism. J. Neurosci. 18:1998;7296-7305.
42. Saluja I., O'Regan M.H., Song D., Phillis J.W. Activation of cPLA2, PKC, and ERKs in the rat cerebral cortex during ischemia/reperfusion. Neurochem. Res. 24:1999;669-677.
43. Satoh T., Nakatsuka D., Watanabe Y., Nagata I., Kikuchi H., Namura S. Neuroprotection by MAPK/ERK kinase inhibition with U0126 against oxidative stress in a mouse neuronal cell line and rat primary cultured cortical neurons. Neurosci. Lett. 288:2000;163-166.
44. Schaeffer H.J., Weber M.J. Mitogen-activated protein kinases: specific messages from ubiquitous messengers. Mol. Cell. Biol. 19:1999;2435-2444.
45. Seger R., Krebs E.G. The MAPK signaling cascade. FASEB J. 9:1995;726-735.
46. Shackelford D.A. Detection of protein kinase activity after renaturation of proteins in SDS-polyacrylamide gels or on membranes. Celis J.E. Cell Biology: A Laboratory Handbook. Vol. 4:1997;466-473 Academic Press, San Diego, CA.
47. Shackelford D.A., Tobaru T., Zhang S., Zivin J.A. Changes in expression of the DNA repair protein complex DNA-dependent protein kinase after ischemia and reperfusion. J. Neurosci. 19:1999;4727-4738.
48. 2+/calmodulin-dependent protein kinase II following spinal cord ischemia. J. Neurochem. 61:1993;738-747.
49. Shackelford D.A., Yeh R.Y. Differential effects of ischemia and reperfusion on c-Jun N-terminal kinase isoform protein and activity. Mol. Brain Res. 94:2001;178-192.
50. Shamloo M., Rytter A., Wieloch T. Activation of the extracellular signal-regulated protein kinase cascade in the hippocampal CA1 region in a rat model of global cerebral ischemic preconditioning. Neuroscience. 93:1999;81-88.
51. Stanciu M., Wang Y., Kentor R., Burke N., Watkins S., Kress G., Reynolds I., Klann E., Angiolieri M.R., Johnson J.W., DeFranco D.B. Persistent activation of ERK contributes to glutamate-induced oxidative toxicity in a neuronal cell line and primary cortical neuron cultures. J. Biol. Chem. 275:2000;12200-12206.
52. Sugino T., Nozaki K., Takagi Y., Hattori I., Hashimoto N., Moriguchi T., Nishida E. Activation of mitogen-activated protein kinases after transient forebrain ischemia in gerbil hippocampus. J. Neurosci. 20:2000;4506-4515.
53. Tan S., Wood M., Maher P. Oxidative stress induces a form of programmed cell death with characteristics of both apoptosis and necrosis in neuronal cells. J. Neurochem. 71:1998;95-103.
54. Wang X., Wang H., Xu L., Rozanski J.D., Sugawara T., Chan P.H., Trzaskos J.M., Feuerstein G.Z. Significant neuroprotection against ischemic brain injury by inhibition of the MEK1 protein kinase in mice: exploration of potential mechanism associated with apoptosis. J. Pharmacol. Exp. Ther. 304:2003;172-178.
55. Whitmarsh A.J., Davis R.J. Structural organization of MAP-kinase signaling modules by scaffold proteins in yeast and mammals. Trends Biochem. Sci. 23:1998;481-485.
56. Wu D.C., Ye W., Che X.M., Yang G.Y. Activation of mitogen-activated protein kinases after permanent cerebral artery occlusion in mouse brain. J. Cereb. Blood Flow Metab. 20:2000;1320-1330.
57. Xia Z., Dickens M., Raingeaud J., Davis R.J., Greenberg M.E. Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis. Science. 270:1995;1326-1331.
58. Zivin J.A., DeGirolami U. Studies of the influence of biogenic amines on central nervous system ischemia. Stroke. 17:1986;509-516.
59. Zivin J.A., DeGirolami U., Hurwitz E.L. A quantitative study of the spectrum of neurological deficits in experimental nervous system ischemia. Arch. Neurol. 39:1982;408-412.